Liberia

MILITARY TIMES by Patrice Kimm                                                                    April 23, 2015

The unprecedented deployment of U.S. troops to West Africa last year as part of the international response to the Ebola crisis saw no American service members contracting the deadly virus.

But five soldiers did fall prey to another disease. They contracted malaria, a concern that underscores the need for continued vaccine research, according to Army Surgeon General Lt. Gen. Patricia Horoho.

Army officials say three troops contracted malaria in Liberia between October and November and two more were suspected of having a malaria infection.

All responded to treatment, Horoho said.

Read complete story.
http://www.militarytimes.com/story/military/benefits/health-care/2015/04/23/us-military-ebola-deployment-malaria/26236769/

AFP 

(Scroll down for complete WHO report                                                                                         April 22, 2015

Geneva - More than 26,000 people have been infected with Ebola since the outbreak began and more than 10,800 have died, the World Health Organization said Wednesday.

The UN health body also warned that the decline in confirmed cases appeared to have stagnated, urging increased efforts to stop transmission of the deadly virus.

In all, 26,079 people have contracted the disease over the past 16 months, and 10,823 of them have died, almost all of them in Guinea, Liberia and Sierra Leone....

In the week leading to April 19, 33 new confirmed cases were reported, with 21 in Guinea, 12 in Sierra Leone and none in Liberia.

That compares to 37 new confirmed cases the week before, and 30 the week before that....

REUTERS by Aharon Begley                                                                    Aug. 22, 2015
NEW YORK --An experimental Ebola drug from Tekmira Pharmaceuticals Corp cured all three monkeys intentionally infected with the virus, scientists reported on Wednesday, the first such success against the strain of Ebola in West Africa's 2014-2015 outbreak.

Although other experimental treatments appeared to help Ebola patients last year, especially in the United States, those one-time uses cannot prove efficacy against the "Makona" strain, since patients' recovery might be due to other causes. Similarly, drugs, including Mapp Biopharmaceutical's ZMapp, cured monkeys in lab experiments, but in a strain of Ebola different from that responsible for the current outbreak, the worst ever recorded.

"We can't say for certain that an experimental drug that works against one strain will work in another, even if they're almost identical genetically," said Thomas Geisbert of the University of Texas Medical Branch, senior author of the study published in the journal Nature.

HUFFINGTON POST by Dr. Simin Nikbin Meydan                                                               April 21, 2015
When the world was devastated by the deadly outbreak of Ebola in West Africa last year, we were given a warning call on many levels. While I was mulling over the whys and hows of the epidemic, my mind automatically went to the role that nutrition can play in helping to stem the spread, and mortality rates, of diseases and perhaps deter future outbreaks.

 The next step my mind took, (admittedly, I research nutrition, immunology and infection in older adults), was to the role nutrition plays in maintaining a robust immune response and fighting against infections particularly in older adults. Remember the SARS outbreak in 2003? SARS (Severe Acute Respiratory Syndrome) is a viral respiratory disease caused by the SARS coronavirus. The outbreak began in southern China and caused an eventual 8,096 cases with 774 deaths reported in multiple countries. The overall mortality rate in aged populations exceeded 50%. Age matters in fighting infections. As we age, our immune systems gray and we need to factor this into our response to outbreaks.

It is telling that infectious epidemics usually originate in areas of the world that suffer from poor nutrition.